Search research articles
Contact Us
Filters
Showing results (21-30 of 33) with videos related to
Page
of 4
Sort By:
Bone Marrow Transplantation
|
June 26, 1999
Multicentre European study comparing selection techniques for the isolation of CD34+ cells
E A de Wynter, D Ryder, F Lanza, et al.
International Journal of Clinical & Laboratory Research
|
January 1, 1993
Soluble interleukin-2 receptor in hairy-cell leukemia: a reliable marker of disease
A Ambrosetti, G Nadali, F Vinante, et al.
International Journal of Cancer
|
March 23, 2000
PCR with degenerate primers for highly conserved DNA polymerase gene of the herpesvirus family shows neither human herpesvirus 8 nor a related variant in bone marrow stromal cells from multiple myeloma patients
M Dominici, M Luppi, D Campioni, et al.
Blood
|
May 16, 1998
Serum level of the soluble form of the CD30 molecule identifies patients with Hodgkin's disease at high risk of unfavorable outcome
G Nadali, L Tavecchia, E Zanolin, et al.
British Journal of Haematology
|
September 12, 1998
Serum levels of p55 and p75 soluble TNF receptors in adult acute leukaemia at diagnosis: correlation with clinical and biological features and outcome
F Vinante, A Rigo, C Tecchio, et al.
Blood Cell Therapy
|
September 12, 2024
Long-term remissions with Gilteritinib in early relapse after allogeneic stem cell transplantation of FLT3/NPM1 mutated acute myeloid leukemia
E Tamellini, M Sorio, A Andreini, et al.
Blood
|
November 15, 1996
p21/WAF1 cyclin-kinase inhibitor expression in non-Hodgkin's lymphomas: a potential marker of p53 tumor-suppressor gene function
M Chilosi, C Doglioni, A Magalini, et al.
International Journal of Clinical & Laboratory Research
|
August 5, 1998
The effectiveness and tolerability of epoetin alfa in patients with multiple myeloma refractory to chemotherapy
F Dammacco, F Silvestris, G L Castoldi, et al.
British Journal of Haematology
|
June 2, 2007
High serum levels of B-lymphocyte stimulator are associated with clinical-pathological features and outcome in classical Hodgkin lymphoma
C Tecchio, G Nadali, P Scapini, et al.
Haematologica
|
March 20, 2001
Serum interleukin-10 levels are an independent prognostic factor for patients with Hodgkin's lymphoma
T P Vassilakopoulos, G Nadali, M K Angelopoulou, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 33) with videos related to
Sort By:
Page
of 4
Bone Marrow Transplantation
|
June 26, 1999
Multicentre European study comparing selection techniques for the isolation of CD34+ cells
E A de Wynter, D Ryder, F Lanza, et al.
International Journal of Clinical & Laboratory Research
|
January 1, 1993
Soluble interleukin-2 receptor in hairy-cell leukemia: a reliable marker of disease
A Ambrosetti, G Nadali, F Vinante, et al.
International Journal of Cancer
|
March 23, 2000
PCR with degenerate primers for highly conserved DNA polymerase gene of the herpesvirus family shows neither human herpesvirus 8 nor a related variant in bone marrow stromal cells from multiple myeloma patients
M Dominici, M Luppi, D Campioni, et al.
Blood
|
May 16, 1998
Serum level of the soluble form of the CD30 molecule identifies patients with Hodgkin's disease at high risk of unfavorable outcome
G Nadali, L Tavecchia, E Zanolin, et al.
British Journal of Haematology
|
September 12, 1998
Serum levels of p55 and p75 soluble TNF receptors in adult acute leukaemia at diagnosis: correlation with clinical and biological features and outcome
F Vinante, A Rigo, C Tecchio, et al.
Blood Cell Therapy
|
September 12, 2024
Long-term remissions with Gilteritinib in early relapse after allogeneic stem cell transplantation of FLT3/NPM1 mutated acute myeloid leukemia
E Tamellini, M Sorio, A Andreini, et al.
Blood
|
November 15, 1996
p21/WAF1 cyclin-kinase inhibitor expression in non-Hodgkin's lymphomas: a potential marker of p53 tumor-suppressor gene function
M Chilosi, C Doglioni, A Magalini, et al.
International Journal of Clinical & Laboratory Research
|
August 5, 1998
The effectiveness and tolerability of epoetin alfa in patients with multiple myeloma refractory to chemotherapy
F Dammacco, F Silvestris, G L Castoldi, et al.
British Journal of Haematology
|
June 2, 2007
High serum levels of B-lymphocyte stimulator are associated with clinical-pathological features and outcome in classical Hodgkin lymphoma
C Tecchio, G Nadali, P Scapini, et al.
Haematologica
|
March 20, 2001
Serum interleukin-10 levels are an independent prognostic factor for patients with Hodgkin's lymphoma
T P Vassilakopoulos, G Nadali, M K Angelopoulou, et al.
Page
of 4